Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Cash Flows From Operating Activities | |
| Net Income | -10,801 |
| Depreciation Amortization | 423 |
| Accounts receivable | 3,375 |
| Other Working Capital | -2,227 |
| Other Operating Activity | -2,476 |
| Operating Cash Flow | $-11,706 |
| Cash Flows From Investing Activities | |
| Investing Cash Flow | $N/A |
| Cash Flows From Financing Activities | |
| Debt Issued | 5,500 |
| Other Financing Activity | 3,356 |
| Financing Cash Flow | $8,856 |
| Beginning Cash Position | 7,452 |
| End Cash Position | 4,602 |
| Net Cash Flow | $-2,850 |
| Free Cash Flow | |
| Operating Cash Flow | -11,706 |
| Free Cash Flow | -11,706 |